Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,008 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immune modulation by zoledronic acid in human myeloma: an advantageous cross-talk between Vγ9Vδ2 T cells, αβ CD8+ T cells, regulatory T cells, and dendritic cells.
Castella B, Riganti C, Fiore F, Pantaleoni F, Canepari ME, Peola S, Foglietta M, Palumbo A, Bosia A, Coscia M, Boccadoro M, Massaia M. Castella B, et al. Among authors: palumbo a. J Immunol. 2011 Aug 15;187(4):1578-90. doi: 10.4049/jimmunol.1002514. Epub 2011 Jul 13. J Immunol. 2011. PMID: 21753152
The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease status.
Foglietta M, Castella B, Mariani S, Coscia M, Godio L, Ferracini R, Ruggeri M, Muccio V, Omedé P, Palumbo A, Boccadoro M, Massaia M. Foglietta M, et al. Among authors: palumbo a. Haematologica. 2014 Oct;99(10):1605-10. doi: 10.3324/haematol.2014.105866. Epub 2014 Jun 27. Haematologica. 2014. PMID: 24972771 Free PMC article.
Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma.
Castella B, Foglietta M, Sciancalepore P, Rigoni M, Coscia M, Griggio V, Vitale C, Ferracini R, Saraci E, Omedé P, Riganti C, Palumbo A, Boccadoro M, Massaia M. Castella B, et al. Among authors: palumbo a. Oncoimmunology. 2015 May 26;4(11):e1047580. doi: 10.1080/2162402X.2015.1047580. eCollection 2015 Nov. Oncoimmunology. 2015. PMID: 26451323 Free PMC article.
New drugs for treatment of multiple myeloma.
Bruno B, Rotta M, Giaccone L, Massaia M, Bertola A, Palumbo A, Boccadoro M. Bruno B, et al. Among authors: palumbo a. Lancet Oncol. 2004 Jul;5(7):430-42. doi: 10.1016/S1470-2045(04)01511-6. Lancet Oncol. 2004. PMID: 15231250 Review.
The treatment of the elderly multiple myeloma patients.
Cavallo F, Ambrosini MT, Rus C, Boccadoro M, Palumbo A. Cavallo F, et al. Among authors: palumbo a. Leuk Lymphoma. 2007 Mar;48(3):469-80. doi: 10.1080/10428190601059852. Leuk Lymphoma. 2007. PMID: 17454586 Review.
Management of myeloma: an Italian perspective.
Bruno B, Gay F, Boccadoro M, Palumbo A. Bruno B, et al. Among authors: palumbo a. Clin Lymphoma Myeloma Leuk. 2011 Jun;11 Suppl 1:S82-6. doi: 10.1016/j.clml.2011.03.026. Epub 2011 May 12. Clin Lymphoma Myeloma Leuk. 2011. PMID: 22035755 Free article.
1,008 results